Arun Sanyal, MD
Gastroenterology · Richmond, VANPI 1629168273
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $619,303 of the $854,809 with a category attached, or 72.4%. It is spread thinly across 41 manufacturers, the largest accounting for just 18.1%. Reporting peaked in 2019 at $188,589 and has fallen 70.7% since, to $55,340 in 2025. Among gastroenterology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 536 payments — averaging $1594.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$155K
- Merck$140K
- Mallinckrodt Hospital Products Inc.$89K
- Pfizer$61K
- Novo Nordisk$60K
- Boehringer Ingelheim International GmbH$57K
- plus $292K from 35 others
Across 614 payments — averaging $7673.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$1.7M
- Intercept Pharmaceuticals, Inc.$645K
- E.r. Squibb & Sons, L.L.C.$586K
- Pfizer$323K
- Madrigal Pharmaceuticals$246K
- Genentech, Inc.$213K
- plus $951K from 15 others
What the payments were for
- Consulting fees$619,30372%
- Speaking & faculty fees$92,10511%
- Travel & lodging$134,47516%
- Food & beverage$8,9271%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCALIVA$11,926
- Repatha$7,787
- XIFAXAN$4,177
- Non-Covered Product$2,956
- ADVIA Immunoassay Reagents/Test Kit/Clinical Utilization$2,951
- MAGNETOM Vida$1,731
- MK-3655$1,640
- REZDIFFRA$1,600
- Skyrizi$1,400
- Atellica$804
- NO PRODUCT DISCUSSED$483
- Korlym$450
- AXIOS$143
How this compares
$854,809 in reported general payments places this provider in the 95th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Richmond
- Michael FuchsRichmond$126K
- Michael ManetasRichmond$125K
- Jasmohan BajajRichmond$72K
- Binu JohnRichmond$33K
- Arthi SanjeeviRichmond$22K
- Henry EllettRichmond$22K
- Ray KeateRichmond$22K
- Tilak ShahRichmond$20K
- Joseph SpataroRichmond$19K
- Richard SterlingRichmond$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.